Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4246

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Cyclobenzaprine HCI extended-release 15 mg capsules, with a quantity of 30 capsules. The manufacturer is Amneal Pharma located in Bridgewater, NJ. The medication is for prescription only and the NDC number is 70518-4246-00. It is important to store the medication at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). For directions on use, refer to the package insert. Keep out of the reach of children.*

FDA Label Image

Structural Formula (Cyclobenzaprine Hydrochloride Extended Release Cap 1)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 2)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 3)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 4)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 5)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 6)

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.